Takeya Masubuchi

562 total citations
8 papers, 315 citations indexed

About

Takeya Masubuchi is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Takeya Masubuchi has authored 8 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in Takeya Masubuchi's work include Immune Cell Function and Interaction (4 papers), T-cell and B-cell Immunology (3 papers) and CAR-T cell therapy research (2 papers). Takeya Masubuchi is often cited by papers focused on Immune Cell Function and Interaction (4 papers), T-cell and B-cell Immunology (3 papers) and CAR-T cell therapy research (2 papers). Takeya Masubuchi collaborates with scholars based in United States, China and Switzerland. Takeya Masubuchi's co-authors include Enfu Hui, Yunlong Zhao, Haopeng Wang, Xiaozheng Xu, Nan Zhang, Ruirui Jing, Xing He, Xinyi Xu, Min Huang and Hua Li and has published in prestigious journals such as Cell, Journal of the American Chemical Society and The Journal of Experimental Medicine.

In The Last Decade

Takeya Masubuchi

7 papers receiving 311 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takeya Masubuchi United States 6 186 180 99 50 30 8 315
Paraskevi Dimou United Kingdom 6 205 1.1× 108 0.6× 87 0.9× 53 1.1× 32 1.1× 8 303
Carla A. Jaeger-Ruckstuhl United States 7 244 1.3× 154 0.9× 99 1.0× 77 1.5× 47 1.6× 12 341
Adam M. Swartz United States 10 196 1.1× 206 1.1× 126 1.3× 45 0.9× 24 0.8× 18 364
Esther Schoutrop Sweden 7 170 0.9× 114 0.6× 69 0.7× 45 0.9× 33 1.1× 8 274
Caiying Jiang China 5 236 1.3× 130 0.7× 61 0.6× 55 1.1× 58 1.9× 7 277
Nicholas F. Kuhn United States 6 217 1.2× 163 0.9× 101 1.0× 60 1.2× 57 1.9× 6 314
Yonggui Tian China 7 280 1.5× 167 0.9× 126 1.3× 70 1.4× 64 2.1× 8 377
Andrea Pepper United Kingdom 8 187 1.0× 132 0.7× 121 1.2× 36 0.7× 42 1.4× 19 348
Dimitrios Alatzoglou Switzerland 2 246 1.3× 198 1.1× 137 1.4× 63 1.3× 42 1.4× 3 409

Countries citing papers authored by Takeya Masubuchi

Since Specialization
Citations

This map shows the geographic impact of Takeya Masubuchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeya Masubuchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeya Masubuchi more than expected).

Fields of papers citing papers by Takeya Masubuchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takeya Masubuchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeya Masubuchi. The network helps show where Takeya Masubuchi may publish in the future.

Co-authorship network of co-authors of Takeya Masubuchi

This figure shows the co-authorship network connecting the top 25 collaborators of Takeya Masubuchi. A scholar is included among the top collaborators of Takeya Masubuchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takeya Masubuchi. Takeya Masubuchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Masubuchi, Takeya, Christine Caron, Jibin Zhang, et al.. (2025). Functional differences between rodent and human PD-1 linked to evolutionary divergence. Science Immunology. 10(103). eads6295–eads6295. 16 indexed citations
2.
Borowska, Marta T., Nathanael A. Caveney, Kevin M. Jude, et al.. (2024). Orientation-dependent CD45 inhibition with viral and engineered ligands. Science Immunology. 9(100). eadp0707–eadp0707.
3.
Chen, Xiaoxia, et al.. (2024). Size-Selective Capturing of Exosomes Using DNA Tripods. Journal of the American Chemical Society. 146(15). 10293–10298. 11 indexed citations
4.
Zhao, Yunlong, Christine Caron, Calvin K. Lee, et al.. (2023). cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8+ T cell function and anti-tumor immunity. Immunity. 56(6). 1187–1203.e12. 43 indexed citations
5.
Xu, Xiaozheng, Jibin Zhang, Alice Sherrard, et al.. (2023). CTLA4 depletes T cell endogenous and trogocytosed B7 ligands via cis-endocytosis. The Journal of Experimental Medicine. 220(7). 25 indexed citations
6.
Podolsky, Kira A., Takeya Masubuchi, Galia T. Debelouchina, Enfu Hui, & Neal K. Devaraj. (2022). In Situ Assembly of Transmembrane Proteins from Expressed and Synthetic Components in Giant Unilamellar Vesicles. ACS Chemical Biology. 17(5). 1015–1021. 1 indexed citations
7.
Wu, Wei, Qiuping Zhou, Takeya Masubuchi, et al.. (2020). Multiple Signaling Roles of CD3ε and Its Application in CAR-T Cell Therapy. Cell. 182(4). 855–871.e23. 137 indexed citations
8.
Xu, Xiaozheng, Takeya Masubuchi, Yunlong Zhao, et al.. (2020). PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2. The Journal of Cell Biology. 219(6). 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026